Search Results

There are 11165 results for: content related to: Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

  1. You have free access to this content
    Atorvastatin for lowering lipids

    Intervention Review

    The Cochrane Library

    Stephen P Adams, Michael Tsang and James M Wright

    Published Online : 11 MAR 2015, DOI: 10.1002/14651858.CD008226.pub3

  2. You have free access to this content
    Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model

    Geriatrics & Gerontology International

    Volume 12, Issue s1, April 2012, Pages: 88–102, Tomohiro Shinozaki, Yutaka Matsuyama, Satoshi Iimuro, Hiroyuki Umegaki, Takashi Sakurai, Atsushi Araki, Yasuo Ohashi, Hideki Ito and the Japanese Elderly Diabetes Intervention Trial Research Group

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1447-0594.2011.00816.x

  3. Effect of Gemfibrozil and Fenofibrate on the Pharmacokinetics of Atorvastatin

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 378–388, Dr Lloyd R. Whitfield, Dr Anthony R. Porcari, Ms Christine Alvey, Dr Robert Abel, Mr William Bullen and Dr Daniel Hartman

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010366446

  4. You have free access to this content
    Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor

    British Journal of Pharmacology

    Volume 165, Issue 5, March 2012, Pages: 1595–1608, E Hoffart, L Ghebreghiorghis, AK Nussler, WE Thasler, TS Weiss, M Schwab and O Burk

    Version of Record online : 10 FEB 2012, DOI: 10.1111/j.1476-5381.2011.01665.x

  5. The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats

    Liver International

    Volume 35, Issue 2, February 2015, Pages: 326–334, Sarai Rodríguez, Imma Raurell, Nahia Ezkurdia, Salvador Augustin, Rafael Esteban, Joan Genescà and María Martell

    Version of Record online : 12 FEB 2014, DOI: 10.1111/liv.12472

  6. You have free access to this content
    Poster Session 4: Portal Hypertension - Experimental

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1173A–1184A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27535

  7. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 11, November 2011, Pages: 1047–1055, J. Gumprecht, M. Gosho, D. Budinski and N. Hounslow

    Version of Record online : 28 SEP 2011, DOI: 10.1111/j.1463-1326.2011.01477.x

  8. You have free access to this content
    The effect of atorvastatin treatment on serum oxysterol concentrations and cytochrome P450 3A4 activity

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 473–479, Janne Hukkanen, Johanna Puurunen, Tuulia Hyötyläinen, Markku J. Savolainen, Aimo Ruokonen, Laure Morin-Papunen, Matej Orešič, Terhi Piltonen and Juha S. Tapanainen

    Version of Record online : 22 JUL 2015, DOI: 10.1111/bcp.12701

  9. Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination Tablet

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 1030–1037, Dr Menger Chung, Mr Albert Calcagni, Dr Paul Glue and Dr Candace Bramson

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006291031

  10. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 2, August 1999, Pages: 118–127, Jari J. Lilja, Kari T. Kivistö and Pertti J. Neuvonen

    Version of Record online : 5 AUG 1999, DOI: 10.1053/cp.1999.v66.100453001

  11. You have free access to this content
    Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 106–115, Ricardo Rodríguez-Calvo, Emma Barroso, Lucía Serrano, Teresa Coll, Rosa M. Sánchez, Manuel Merlos, Xavier Palomer, Juan C. Laguna and Manuel Vázquez-Carrera

    Version of Record online : 5 AUG 2008, DOI: 10.1002/hep.22570

  12. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice

    Molecular Carcinogenesis

    Volume 52, Issue 9, September 2013, Pages: 739–750, Jie Liao, Yeon T. Chung, Allison L. Yang, Meng Zhang, Haonan Li, Wanying Zhang, Liang Yan and Guang-Yu Yang

    Version of Record online : 30 APR 2012, DOI: 10.1002/mc.21916

  13. No Pharmacokinetic or Pharmacodynamic Interaction Between Atorvastatin and the Oral Direct Thrombin Inhibitor Ximelagatran

    The Journal of Clinical Pharmacology

    Volume 44, Issue 8, August 2004, Pages: 928–934, Dr Troy C. Sarich, Dr Kajs-Marie Schützer, Hassan Dorani, Dr Ulrika Wall, Dr Inge Kalies, Lis Ohlsson and Dr Ulf G. Eriksson

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268047

  14. A Study of the Pharmacokinetic Interaction of Istradefylline, a Novel Therapeutic for Parkinson's Disease, and Atorvastatin

    The Journal of Clinical Pharmacology

    Volume 48, Issue 9, September 2008, Pages: 1092–1098, Dr N. Rao, Dr B. Dvorchik, Dr N. Sussman, Ms H. Wang, Mr K. Yamamoto, Dr A. Mori, Mr T. Uchimura and Dr P. Chaikin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008320924

  15. You have full text access to this OnlineOpen article
    Thyroid hormone β receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys

    British Journal of Pharmacology

    Volume 156, Issue 3, February 2009, Pages: 454–465, BR Ito, B-H Zhang, EE Cable, X Song, JM Fujitaki, DA MacKenna, CE Wilker, B Chi, PD Van Poelje, DL Linemeyer and MD Erion

    Version of Record online : 22 JAN 2009, DOI: 10.1111/j.1750-3639.2009.00038.x

  16. Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 2, February 2007, Pages: 194–204, Y Y Lau, Y Huang, L Frassetto and L Z Benet

    Version of Record online : 27 DEC 2006, DOI: 10.1038/sj.clpt.6100038

  17. You have free access to this content
    Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin

    International Journal of Cancer

    Volume 131, Issue 6, 15 September 2012, Pages: 1277–1286, Michael A. Pereira, Blake M. Warner, Thomas J. Knobloch, Christopher M. Weghorst, Ronald A. Lubet, Vernon E. Steele and Bruce C. Casto

    Version of Record online : 31 JAN 2012, DOI: 10.1002/ijc.27395

  18. Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1323–1338, Dr Sujata Vaidyanathan, Dr Gian Camenisch, Dr Helmut Schuetz, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noelle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008323258

  19. You have free access to this content
    Atorvastatin But Not Elocalcitol Increases Sildenafil Responsiveness in Spontaneously Hypertensive Rats by Regulating the RhoA/ROCK Pathway

    Journal of Andrology

    Volume 29, Issue 1, January-February 2008, Pages: 70–84, Benedetta Fibbi, Annamaria Morelli, Mirca Marini, Xin-Hua Zhang, Rosa Mancina, Linda Vignozzi, Sandra Filippi, Aravinda Chavalmane, Enrico Silvestrini, Enrico Colli, Luciano Adorini, Gabriella Barbara Vannelli and Mario Maggi

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.107.003152

  20. Atorvastatin Calcium: An Addition to HMG-CoA Reductase Inhibitors

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 6, November-December 1997, Pages: 1157–1177, Pang H. Chong and John D. Seeger

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03081.x